{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-047690","form_type":"8-K","ticker":"PEPG","cik":"0001835597","company_name":"PepGen Inc.","filed_at":"2025-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.175994+00:00","generated_at":"2026-05-24T02:20:14.392236+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"PepGen expands board to eight with appointments of Finer and Wyman","bullets":["Mitchell Finer (PhD), former CSO at bluebird bio, and Lisa Wyman, CTO at Scholar Rock, join board.","Board expands from six to eight; Finer Class III director, Wyman Class I director.","Each receives initial option award of 26,000 shares, vesting over three years.","Standard non-employee director compensation and indemnification agreements apply.","CEO cites their expertise in scaling manufacturing and gene therapy development."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-047690","json":"https://secwatch.observer/filing/0000950170-25-047690.json","markdown":"https://secwatch.observer/filing/0000950170-25-047690.md","text":"https://secwatch.observer/filing/0000950170-25-047690.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835597/000095017025047690/0000950170-25-047690-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835597/000095017025047690/pepg-20250327.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T02:20:14.392236+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"990ead31cf","claim":"Lisa Wyman was appointed as Director at PepGen Inc..","evidence_excerpt":"On March 27, 2025, the Board of Directors (the “Board”) of PepGen Inc. (“PepGen” or the “Company”), on the recommendation of the Nominating and Corporate Governance Committee of the Board, unanimously appointed Mitchell Finer, Ph.D. and Lisa Wyman to fill newly created vacancies on the Board resulting from the expansion of the number of members of the Board from six to eight.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835597/000095017025047690/0000950170-25-047690-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"cab422aade","claim":"Mitchell Finer was appointed as Director at PepGen Inc..","evidence_excerpt":"On March 27, 2025, the Board of Directors (the “Board”) of PepGen Inc. (“PepGen” or the “Company”), on the recommendation of the Nominating and Corporate Governance Committee of the Board, unanimously appointed Mitchell Finer, Ph.D. and Lisa Wyman to fill newly created vacancies on the Board resulting from the expansion of the number of members of the Board from six to eight.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835597/000095017025047690/0000950170-25-047690-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}